

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 7.20361566 |
| 2 | viral transcription (GO:0019083) | 6.56080526 |
| 3 | translational termination (GO:0006415) | 6.27482249 |
| 4 | pyrimidine nucleoside salvage (GO:0043097) | 6.15031520 |
| 5 | pyrimidine-containing compound salvage (GO:0008655) | 6.15031520 |
| 6 | DNA deamination (GO:0045006) | 5.99382139 |
| 7 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.62695639 |
| 8 | translational elongation (GO:0006414) | 5.61053593 |
| 9 | nucleotide salvage (GO:0043173) | 5.55070358 |
| 10 | ribosomal small subunit biogenesis (GO:0042274) | 5.51455952 |
| 11 | protein targeting to ER (GO:0045047) | 5.46710576 |
| 12 | cotranslational protein targeting to membrane (GO:0006613) | 5.45983161 |
| 13 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.19269442 |
| 14 | protein localization to endoplasmic reticulum (GO:0070972) | 5.16122327 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 4.91365054 |
| 16 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.89142673 |
| 17 | viral life cycle (GO:0019058) | 4.86561968 |
| 18 | cellular protein complex disassembly (GO:0043624) | 4.78622301 |
| 19 | translational initiation (GO:0006413) | 4.69155950 |
| 20 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.66559000 |
| 21 | maturation of SSU-rRNA (GO:0030490) | 4.62640496 |
| 22 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.60710690 |
| 23 | DNA strand elongation (GO:0022616) | 4.41446163 |
| 24 | protein complex disassembly (GO:0043241) | 4.34480056 |
| 25 | macromolecular complex disassembly (GO:0032984) | 4.06570384 |
| 26 | response to peptidoglycan (GO:0032494) | 4.06113023 |
| 27 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.86433647 |
| 28 | telomere maintenance via recombination (GO:0000722) | 3.85427502 |
| 29 | ribosomal large subunit biogenesis (GO:0042273) | 3.84291233 |
| 30 | DNA unwinding involved in DNA replication (GO:0006268) | 3.81276366 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.69618593 |
| 32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.69618593 |
| 33 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.66858049 |
| 34 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.65128027 |
| 35 | protein targeting to membrane (GO:0006612) | 3.61023175 |
| 36 | translation (GO:0006412) | 3.60662734 |
| 37 | UMP biosynthetic process (GO:0006222) | 3.55247266 |
| 38 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 3.55247266 |
| 39 | UMP metabolic process (GO:0046049) | 3.55247266 |
| 40 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 3.55247266 |
| 41 | DNA replication initiation (GO:0006270) | 3.53652763 |
| 42 | mitotic recombination (GO:0006312) | 3.50633926 |
| 43 | mRNA catabolic process (GO:0006402) | 3.47415515 |
| 44 | immunoglobulin mediated immune response (GO:0016064) | 3.45778742 |
| 45 | regulation of mast cell degranulation (GO:0043304) | 3.44584732 |
| 46 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.43449097 |
| 47 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.43449097 |
| 48 | modulation by symbiont of host immune response (GO:0052553) | 3.43449097 |
| 49 | positive regulation by symbiont of host defense response (GO:0052509) | 3.43449097 |
| 50 | modulation by symbiont of host defense response (GO:0052031) | 3.43449097 |
| 51 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.43449097 |
| 52 | formation of translation preinitiation complex (GO:0001731) | 3.42720103 |
| 53 | detection of bacterium (GO:0016045) | 3.39318256 |
| 54 | telomere maintenance via telomere lengthening (GO:0010833) | 3.32432107 |
| 55 | purine nucleotide salvage (GO:0032261) | 3.31707669 |
| 56 | RNA catabolic process (GO:0006401) | 3.31370005 |
| 57 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.31251394 |
| 58 | CTP metabolic process (GO:0046036) | 3.30440251 |
| 59 | CTP biosynthetic process (GO:0006241) | 3.30440251 |
| 60 | detection of other organism (GO:0098543) | 3.27471322 |
| 61 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.26517495 |
| 62 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.23474237 |
| 63 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.20909078 |
| 64 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.15708530 |
| 65 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.15561553 |
| 66 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.14783150 |
| 67 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.12344209 |
| 68 | neutrophil mediated immunity (GO:0002446) | 3.11708212 |
| 69 | regulation of protein heterodimerization activity (GO:0043497) | 3.11307656 |
| 70 | negative regulation of interleukin-12 production (GO:0032695) | 3.10959418 |
| 71 | positive regulation of B cell differentiation (GO:0045579) | 3.06442861 |
| 72 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.05962545 |
| 73 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.05478243 |
| 74 | response to muramyl dipeptide (GO:0032495) | 3.03738212 |
| 75 | NIK/NF-kappaB signaling (GO:0038061) | 2.99399315 |
| 76 | amino sugar catabolic process (GO:0046348) | 2.96366273 |
| 77 | negative regulation of phagocytosis (GO:0050765) | 2.96207203 |
| 78 | respiratory burst (GO:0045730) | 2.92280362 |
| 79 | positive regulation of antigen processing and presentation (GO:0002579) | 2.91541660 |
| 80 | modulation by virus of host process (GO:0019054) | 2.91343857 |
| 81 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.90229581 |
| 82 | UV protection (GO:0009650) | 2.88643100 |
| 83 | negative regulation of cell killing (GO:0031342) | 2.88162687 |
| 84 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.88162687 |
| 85 | negative regulation of RNA splicing (GO:0033119) | 2.87914871 |
| 86 | pseudouridine synthesis (GO:0001522) | 2.87811141 |
| 87 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.86115192 |
| 88 | negative regulation of B cell apoptotic process (GO:0002903) | 2.83588122 |
| 89 | ncRNA 3-end processing (GO:0043628) | 2.83468161 |
| 90 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.82271376 |
| 91 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.81700044 |
| 92 | positive regulation of mast cell degranulation (GO:0043306) | 2.81700044 |
| 93 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.81618097 |
| 94 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.80895336 |
| 95 | regulation of leukocyte degranulation (GO:0043300) | 2.79404393 |
| 96 | activation of MAPKKK activity (GO:0000185) | 2.78494381 |
| 97 | leukocyte aggregation (GO:0070486) | 2.75949300 |
| 98 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.75586268 |
| 99 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.74628125 |
| 100 | rRNA processing (GO:0006364) | 2.73711588 |
| 101 | establishment of integrated proviral latency (GO:0075713) | 2.73205432 |
| 102 | GDP-mannose metabolic process (GO:0019673) | 2.72776882 |
| 103 | positive regulation of mast cell activation (GO:0033005) | 2.71471705 |
| 104 | modulation by symbiont of host cellular process (GO:0044068) | 2.71198356 |
| 105 | regulation of antigen processing and presentation (GO:0002577) | 2.71161044 |
| 106 | neutrophil activation (GO:0042119) | 2.70827203 |
| 107 | negative regulation of interleukin-8 production (GO:0032717) | 2.70307752 |
| 108 | DNA replication checkpoint (GO:0000076) | 2.70109183 |
| 109 | cellular response to type I interferon (GO:0071357) | 2.69625623 |
| 110 | type I interferon signaling pathway (GO:0060337) | 2.69625623 |
| 111 | macrophage activation involved in immune response (GO:0002281) | 2.68125912 |
| 112 | protein localization to kinetochore (GO:0034501) | 2.67841430 |
| 113 | T cell apoptotic process (GO:0070231) | 2.65706934 |
| 114 | pinocytosis (GO:0006907) | 2.65262864 |
| 115 | regulation of superoxide anion generation (GO:0032928) | 2.64864923 |
| 116 | granulocyte activation (GO:0036230) | 2.64514958 |
| 117 | response to type I interferon (GO:0034340) | 2.64152767 |
| 118 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.63494366 |
| 119 | cellular metabolic compound salvage (GO:0043094) | 2.63381233 |
| 120 | translesion synthesis (GO:0019985) | 2.63206547 |
| 121 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.62603113 |
| 122 | rRNA metabolic process (GO:0016072) | 2.61637412 |
| 123 | detection of external biotic stimulus (GO:0098581) | 2.61490375 |
| 124 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.60893201 |
| 125 | protein maturation by protein folding (GO:0022417) | 2.60556400 |
| 126 | barbed-end actin filament capping (GO:0051016) | 2.58424149 |
| 127 | nucleoside salvage (GO:0043174) | 2.56621755 |
| 128 | nucleobase biosynthetic process (GO:0046112) | 2.54908794 |
| 129 | myeloid cell activation involved in immune response (GO:0002275) | 2.54026456 |
| 130 | cellular component biogenesis (GO:0044085) | 2.53964724 |
| 131 | positive regulation of T cell apoptotic process (GO:0070234) | 2.53557816 |
| 132 | purine-containing compound salvage (GO:0043101) | 2.52996706 |
| 133 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.52584215 |
| 134 | protein retention in ER lumen (GO:0006621) | 2.51930519 |
| 135 | response to folic acid (GO:0051593) | 2.51498867 |
| 136 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.49721287 |
| 137 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.46670428 |
| 138 | protein localization to chromosome, centromeric region (GO:0071459) | 2.45312873 |
| 139 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.44799725 |
| 140 | spliceosomal snRNP assembly (GO:0000387) | 2.44234801 |
| 141 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.43923759 |
| 142 | telomere maintenance (GO:0000723) | 2.42177433 |
| 143 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.41711274 |
| 144 | telomere organization (GO:0032200) | 2.41201313 |
| 145 | establishment of protein localization to membrane (GO:0090150) | 2.40302084 |
| 146 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.39852394 |
| 147 | response to interferon-beta (GO:0035456) | 2.38630255 |
| 148 | IMP biosynthetic process (GO:0006188) | 2.38601014 |
| 149 | lymphocyte apoptotic process (GO:0070227) | 2.37569773 |
| 150 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.37149152 |
| 151 | cellular response to zinc ion (GO:0071294) | 2.36729113 |
| 152 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.35331286 |
| 153 | base-excision repair (GO:0006284) | 2.34068710 |
| 154 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.32436838 |
| 155 | protein targeting (GO:0006605) | 2.32180083 |
| 156 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.31173251 |
| 157 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.30343318 |
| 158 | IMP metabolic process (GO:0046040) | 2.30245391 |
| 159 | folic acid metabolic process (GO:0046655) | 2.27809935 |
| 160 | establishment of protein localization to organelle (GO:0072594) | 2.27092805 |
| 161 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.26451457 |
| 162 | deoxyribonucleotide catabolic process (GO:0009264) | 2.25859969 |
| 163 | ribosome biogenesis (GO:0042254) | 2.25802725 |
| 164 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.25190174 |
| 165 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.25190174 |
| 166 | CENP-A containing nucleosome assembly (GO:0034080) | 2.23657482 |
| 167 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.23319244 |
| 168 | viral mRNA export from host cell nucleus (GO:0046784) | 2.22672007 |
| 169 | metallo-sulfur cluster assembly (GO:0031163) | 2.22556223 |
| 170 | iron-sulfur cluster assembly (GO:0016226) | 2.22556223 |
| 171 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.22555879 |
| 172 | oxidative phosphorylation (GO:0006119) | 2.22232727 |
| 173 | chromatin remodeling at centromere (GO:0031055) | 2.20694838 |
| 174 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.20439931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.19017176 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.07072497 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.51796657 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.46639481 |
| 5 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.75547404 |
| 6 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.60405412 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.54972876 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.48444007 |
| 9 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.47482156 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.39883399 |
| 11 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.37696868 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.33689614 |
| 13 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.32430993 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.30906976 |
| 15 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26483889 |
| 16 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.25064275 |
| 17 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.24447151 |
| 18 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.20485700 |
| 19 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.20325661 |
| 20 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.19506667 |
| 21 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.17020714 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.16862881 |
| 23 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.13172956 |
| 24 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.12372996 |
| 25 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.11848379 |
| 26 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.11170888 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.09025077 |
| 28 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.01241771 |
| 29 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.94450349 |
| 30 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93936714 |
| 31 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.90971632 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.89121372 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.87129890 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.87089646 |
| 35 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.86549281 |
| 36 | P68_20966046_ChIP-Seq_HELA_Human | 1.86086013 |
| 37 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.84332800 |
| 38 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.80969929 |
| 39 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.76782185 |
| 40 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76475702 |
| 41 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.76421599 |
| 42 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.76239489 |
| 43 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.74435295 |
| 44 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.73635055 |
| 45 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.70686890 |
| 46 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.70464638 |
| 47 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.70262756 |
| 48 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.69466077 |
| 49 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.65703395 |
| 50 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.65614090 |
| 51 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65126837 |
| 52 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.64994086 |
| 53 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.64566380 |
| 54 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.64205637 |
| 55 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.63897963 |
| 56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62326776 |
| 57 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.59009667 |
| 58 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.58459372 |
| 59 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.56556610 |
| 60 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.52602813 |
| 61 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.51403232 |
| 62 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.49647755 |
| 63 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.47553581 |
| 64 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.47274500 |
| 65 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.46128080 |
| 66 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.44092004 |
| 67 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.43722968 |
| 68 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.43276579 |
| 69 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.43211381 |
| 70 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.42929653 |
| 71 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.41427519 |
| 72 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.39472841 |
| 73 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.39012818 |
| 74 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.37381904 |
| 75 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.36771309 |
| 76 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.35946198 |
| 77 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.35548340 |
| 78 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.34645105 |
| 79 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.33451319 |
| 80 | * MAF_26560356_Chip-Seq_TH1_Human | 1.33043416 |
| 81 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.32972556 |
| 82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32829275 |
| 83 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31674963 |
| 84 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.30833877 |
| 85 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.30267097 |
| 86 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.30247946 |
| 87 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.29602541 |
| 88 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.29290662 |
| 89 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.28565081 |
| 90 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26971496 |
| 91 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.26784124 |
| 92 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.26668851 |
| 93 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.26396398 |
| 94 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.25883798 |
| 95 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24588599 |
| 96 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.22652576 |
| 97 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.22213853 |
| 98 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.20854311 |
| 99 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.20094546 |
| 100 | SA1_27219007_Chip-Seq_Bcells_Human | 1.18870443 |
| 101 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18807865 |
| 102 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18021916 |
| 103 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18005463 |
| 104 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.17999444 |
| 105 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.16885758 |
| 106 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.16728270 |
| 107 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.16392518 |
| 108 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.15894769 |
| 109 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15415925 |
| 110 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.15399489 |
| 111 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.15254480 |
| 112 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.14623070 |
| 113 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13825043 |
| 114 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13570784 |
| 115 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.13198867 |
| 116 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.12347818 |
| 117 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.12207241 |
| 118 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11978972 |
| 119 | MYB_26560356_Chip-Seq_TH2_Human | 1.11651762 |
| 120 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.11300122 |
| 121 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10861607 |
| 122 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10822192 |
| 123 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.10737762 |
| 124 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.10519758 |
| 125 | MAF_26560356_Chip-Seq_TH2_Human | 1.10173996 |
| 126 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10075610 |
| 127 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.10030821 |
| 128 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.09942384 |
| 129 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.09076704 |
| 130 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09002226 |
| 131 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.08933850 |
| 132 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.08877706 |
| 133 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.08753705 |
| 134 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.08633265 |
| 135 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08450595 |
| 136 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08058787 |
| 137 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.07936660 |
| 138 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07888646 |
| 139 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07447256 |
| 140 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.07349155 |
| 141 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.07190223 |
| 142 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07145792 |
| 143 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06988732 |
| 144 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.06265055 |
| 145 | MYB_26560356_Chip-Seq_TH1_Human | 1.06138522 |
| 146 | SPI1_23127762_ChIP-Seq_K562_Human | 1.05820862 |
| 147 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.05796543 |
| 148 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05650611 |
| 149 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.05335441 |
| 150 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.05066604 |
| 151 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.03753953 |
| 152 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.03340747 |
| 153 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03229650 |
| 154 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02346259 |
| 155 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02291216 |
| 156 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01839334 |
| 157 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01170038 |
| 158 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.00515330 |
| 159 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.96380162 |
| 160 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.95007987 |
| 161 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.92815202 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.44726149 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.41075997 |
| 3 | MP0002396_abnormal_hematopoietic_system | 3.31179726 |
| 4 | MP0006082_CNS_inflammation | 2.84001203 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.61499423 |
| 6 | MP0000685_abnormal_immune_system | 2.48215188 |
| 7 | MP0010094_abnormal_chromosome_stability | 2.42051514 |
| 8 | MP0004957_abnormal_blastocyst_morpholog | 2.40535329 |
| 9 | MP0000490_abnormal_crypts_of | 2.39589222 |
| 10 | MP0008260_abnormal_autophagy | 2.38822178 |
| 11 | MP0006054_spinal_hemorrhage | 2.27681192 |
| 12 | MP0003111_abnormal_nucleus_morphology | 2.24556363 |
| 13 | MP0003077_abnormal_cell_cycle | 2.23879750 |
| 14 | MP0001545_abnormal_hematopoietic_system | 2.12747133 |
| 15 | MP0005397_hematopoietic_system_phenotyp | 2.12747133 |
| 16 | MP0009379_abnormal_foot_pigmentation | 2.12733476 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 2.11821557 |
| 18 | MP0003436_decreased_susceptibility_to | 2.10879341 |
| 19 | MP0002398_abnormal_bone_marrow | 2.00624600 |
| 20 | MP0004808_abnormal_hematopoietic_stem | 1.98060687 |
| 21 | MP0001800_abnormal_humoral_immune | 1.97313199 |
| 22 | MP0009785_altered_susceptibility_to | 1.94975563 |
| 23 | MP0003763_abnormal_thymus_physiology | 1.94415996 |
| 24 | MP0008007_abnormal_cellular_replicative | 1.89694966 |
| 25 | MP0000689_abnormal_spleen_morphology | 1.81877265 |
| 26 | MP0002722_abnormal_immune_system | 1.79769779 |
| 27 | MP0002166_altered_tumor_susceptibility | 1.77908130 |
| 28 | MP0002653_abnormal_ependyma_morphology | 1.77728437 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.76807649 |
| 30 | MP0005025_abnormal_response_to | 1.76317134 |
| 31 | MP0005451_abnormal_body_composition | 1.74260185 |
| 32 | MP0001853_heart_inflammation | 1.72413118 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.71538041 |
| 34 | MP0001819_abnormal_immune_cell | 1.68448509 |
| 35 | MP0000716_abnormal_immune_system | 1.67916666 |
| 36 | MP0002429_abnormal_blood_cell | 1.66578409 |
| 37 | MP0003279_aneurysm | 1.62057417 |
| 38 | MP0009764_decreased_sensitivity_to | 1.61401774 |
| 39 | MP0002723_abnormal_immune_serum | 1.60630693 |
| 40 | MP0005000_abnormal_immune_tolerance | 1.57682084 |
| 41 | MP0003186_abnormal_redox_activity | 1.57005635 |
| 42 | MP0003806_abnormal_nucleotide_metabolis | 1.56141112 |
| 43 | MP0009840_abnormal_foam_cell | 1.56127141 |
| 44 | MP0002019_abnormal_tumor_incidence | 1.55688109 |
| 45 | MP0004858_abnormal_nervous_system | 1.54489321 |
| 46 | MP0005075_abnormal_melanosome_morpholog | 1.54209441 |
| 47 | MP0005671_abnormal_response_to | 1.52307455 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.51523012 |
| 49 | MP0005464_abnormal_platelet_physiology | 1.50500272 |
| 50 | MP0005174_abnormal_tail_pigmentation | 1.49925652 |
| 51 | MP0001873_stomach_inflammation | 1.48670840 |
| 52 | MP0008058_abnormal_DNA_repair | 1.48563573 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.46622513 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.46560820 |
| 55 | MP0009278_abnormal_bone_marrow | 1.46333638 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.42536066 |
| 57 | MP0002405_respiratory_system_inflammati | 1.41850987 |
| 58 | MP0002419_abnormal_innate_immunity | 1.41610966 |
| 59 | MP0001790_abnormal_immune_system | 1.41577762 |
| 60 | MP0005387_immune_system_phenotype | 1.41577762 |
| 61 | MP0000858_altered_metastatic_potential | 1.38497787 |
| 62 | MP0003075_altered_response_to | 1.38077075 |
| 63 | MP0003303_peritoneal_inflammation | 1.35841363 |
| 64 | MP0002132_abnormal_respiratory_system | 1.35566535 |
| 65 | MP0001542_abnormal_bone_strength | 1.34537629 |
| 66 | MP0002148_abnormal_hypersensitivity_rea | 1.31847783 |
| 67 | MP0002163_abnormal_gland_morphology | 1.30922714 |
| 68 | MP0006036_abnormal_mitochondrial_physio | 1.27674400 |
| 69 | MP0002006_tumorigenesis | 1.27220660 |
| 70 | MP0008057_abnormal_DNA_replication | 1.24877135 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 1.22890786 |
| 72 | MP0004510_myositis | 1.22711538 |
| 73 | MP0001845_abnormal_inflammatory_respons | 1.22221226 |
| 74 | MP0000313_abnormal_cell_death | 1.19993414 |
| 75 | MP0005390_skeleton_phenotype | 1.19529240 |
| 76 | MP0000350_abnormal_cell_proliferation | 1.17693979 |
| 77 | MP0000604_amyloidosis | 1.13000654 |
| 78 | MP0003724_increased_susceptibility_to | 1.11583690 |
| 79 | MP0008932_abnormal_embryonic_tissue | 1.08970395 |
| 80 | MP0008469_abnormal_protein_level | 1.08502862 |
| 81 | MP0000681_abnormal_thyroid_gland | 1.06399402 |
| 82 | MP0003866_abnormal_defecation | 1.05554715 |
| 83 | MP0003191_abnormal_cellular_cholesterol | 1.04639807 |
| 84 | MP0002095_abnormal_skin_pigmentation | 1.04592098 |
| 85 | MP0010307_abnormal_tumor_latency | 1.04503950 |
| 86 | MP0001730_embryonic_growth_arrest | 1.02348733 |
| 87 | MP0003300_gastrointestinal_ulcer | 1.00854502 |
| 88 | MP0000750_abnormal_muscle_regeneration | 1.00152222 |
| 89 | MP0002998_abnormal_bone_remodeling | 0.99994719 |
| 90 | MP0005381_digestive/alimentary_phenotyp | 0.98815739 |
| 91 | MP0005220_abnormal_exocrine_pancreas | 0.97286656 |
| 92 | MP0003786_premature_aging | 0.95310215 |
| 93 | MP0001849_ear_inflammation | 0.92187591 |
| 94 | MP0000598_abnormal_liver_morphology | 0.89675747 |
| 95 | MP0003183_abnormal_peptide_metabolism | 0.89540480 |
| 96 | MP0000678_abnormal_parathyroid_gland | 0.87799237 |
| 97 | MP0000358_abnormal_cell_content/ | 0.87738149 |
| 98 | MP0005165_increased_susceptibility_to | 0.87271978 |
| 99 | MP0002080_prenatal_lethality | 0.87139886 |
| 100 | MP0000477_abnormal_intestine_morphology | 0.85876213 |
| 101 | MP0005310_abnormal_salivary_gland | 0.84815105 |
| 102 | MP0004947_skin_inflammation | 0.84468290 |
| 103 | MP0003123_paternal_imprinting | 0.82970758 |
| 104 | MP0005083_abnormal_biliary_tract | 0.82406683 |
| 105 | MP0001533_abnormal_skeleton_physiology | 0.82004560 |
| 106 | MP0001663_abnormal_digestive_system | 0.81678015 |
| 107 | MP0001958_emphysema | 0.80451177 |
| 108 | MP0001348_abnormal_lacrimal_gland | 0.79761993 |
| 109 | MP0005166_decreased_susceptibility_to | 0.79082472 |
| 110 | MP0003828_pulmonary_edema | 0.76459766 |
| 111 | MP0005023_abnormal_wound_healing | 0.75745548 |
| 112 | MP0009643_abnormal_urine_homeostasis | 0.75468346 |
| 113 | MP0005319_abnormal_enzyme/_coenzyme | 0.75223673 |
| 114 | MP0003795_abnormal_bone_structure | 0.74727144 |
| 115 | MP0009765_abnormal_xenobiotic_induced | 0.73689078 |
| 116 | MP0000015_abnormal_ear_pigmentation | 0.73434664 |
| 117 | MP0008004_abnormal_stomach_pH | 0.73024622 |
| 118 | MP0000609_abnormal_liver_physiology | 0.72841704 |
| 119 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71888264 |
| 120 | MP0001764_abnormal_homeostasis | 0.70780198 |
| 121 | MP0003705_abnormal_hypodermis_morpholog | 0.70554408 |
| 122 | MP0003329_amyloid_beta_deposits | 0.70392796 |
| 123 | MP0003567_abnormal_fetal_cardiomyocyte | 0.70284674 |
| 124 | MP0005360_urolithiasis | 0.69393386 |
| 125 | MP0002254_reproductive_system_inflammat | 0.68858613 |
| 126 | MP0001697_abnormal_embryo_size | 0.68533564 |
| 127 | MP0000343_altered_response_to | 0.68306917 |
| 128 | MP0004185_abnormal_adipocyte_glucose | 0.67710259 |
| 129 | MP0009763_increased_sensitivity_to | 0.67623579 |
| 130 | MP0002970_abnormal_white_adipose | 0.67534346 |
| 131 | MP0005257_abnormal_intraocular_pressure | 0.67259213 |
| 132 | MP0005670_abnormal_white_adipose | 0.66372726 |
| 133 | MP0002138_abnormal_hepatobiliary_system | 0.66111606 |
| 134 | MP0002933_joint_inflammation | 0.65922635 |
| 135 | MP0003448_altered_tumor_morphology | 0.65475653 |
| 136 | MP0009931_abnormal_skin_appearance | 0.63752084 |
| 137 | MP0001915_intracranial_hemorrhage | 0.62635702 |
| 138 | MP0005365_abnormal_bile_salt | 0.62000912 |
| 139 | MP0006035_abnormal_mitochondrial_morpho | 0.60899210 |
| 140 | MP0003172_abnormal_lysosome_physiology | 0.60149210 |
| 141 | MP0002089_abnormal_postnatal_growth/wei | 0.59019007 |
| 142 | MP0002277_abnormal_respiratory_mucosa | 0.56250237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.23315149 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 6.10390375 |
| 3 | Reticulocytopenia (HP:0001896) | 5.40027404 |
| 4 | Thrombocytosis (HP:0001894) | 4.48288222 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 3.92256808 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.92256808 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.92256808 |
| 8 | Abnormality of macrophages (HP:0004311) | 3.89902254 |
| 9 | Pallor (HP:0000980) | 3.81744444 |
| 10 | Achilles tendon contracture (HP:0001771) | 3.73058087 |
| 11 | Aplastic anemia (HP:0001915) | 3.70749774 |
| 12 | Macrocytic anemia (HP:0001972) | 3.62679275 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.50312713 |
| 14 | IgM deficiency (HP:0002850) | 3.34383451 |
| 15 | Obstructive lung disease (HP:0006536) | 3.33583733 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 3.33583733 |
| 17 | Abnormality of the Achilles tendon (HP:0005109) | 3.25448194 |
| 18 | Vertebral compression fractures (HP:0002953) | 3.19538605 |
| 19 | Cellulitis (HP:0100658) | 3.17933308 |
| 20 | Dysostosis multiplex (HP:0000943) | 3.12244396 |
| 21 | Petechiae (HP:0000967) | 3.04266791 |
| 22 | Chronic otitis media (HP:0000389) | 3.01914022 |
| 23 | Oral leukoplakia (HP:0002745) | 2.82250406 |
| 24 | Reduced antithrombin III activity (HP:0001976) | 2.81582355 |
| 25 | Purpura (HP:0000979) | 2.81354527 |
| 26 | Agammaglobulinemia (HP:0004432) | 2.79651974 |
| 27 | Recurrent bronchitis (HP:0002837) | 2.77042867 |
| 28 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.76751452 |
| 29 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.76751452 |
| 30 | Abnormality of B cell number (HP:0010975) | 2.75560881 |
| 31 | B lymphocytopenia (HP:0010976) | 2.75560881 |
| 32 | Amyloidosis (HP:0011034) | 2.71065806 |
| 33 | Recurrent viral infections (HP:0004429) | 2.70828664 |
| 34 | Increased cerebral lipofuscin (HP:0011813) | 2.66803461 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 2.65374616 |
| 36 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.64921056 |
| 37 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.64921056 |
| 38 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.64921056 |
| 39 | Hepatosplenomegaly (HP:0001433) | 2.63811215 |
| 40 | Papilloma (HP:0012740) | 2.63031972 |
| 41 | Verrucae (HP:0200043) | 2.63031972 |
| 42 | Systemic lupus erythematosus (HP:0002725) | 2.62788938 |
| 43 | Orchitis (HP:0100796) | 2.62300175 |
| 44 | Increased IgE level (HP:0003212) | 2.60283806 |
| 45 | Multiple enchondromatosis (HP:0005701) | 2.59466401 |
| 46 | Meningitis (HP:0001287) | 2.58282229 |
| 47 | Type I transferrin isoform profile (HP:0003642) | 2.55899871 |
| 48 | Abnormality of T cell physiology (HP:0011840) | 2.54598107 |
| 49 | Hypertensive crisis (HP:0100735) | 2.52756382 |
| 50 | Hepatic necrosis (HP:0002605) | 2.51838065 |
| 51 | Microretrognathia (HP:0000308) | 2.51574840 |
| 52 | Panhypogammaglobulinemia (HP:0003139) | 2.49030386 |
| 53 | Stomatitis (HP:0010280) | 2.43068583 |
| 54 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.40959605 |
| 55 | Mucopolysacchariduria (HP:0008155) | 2.40959605 |
| 56 | Prolonged neonatal jaundice (HP:0006579) | 2.40884792 |
| 57 | Abnormality of reticulocytes (HP:0004312) | 2.40245190 |
| 58 | Gastrointestinal inflammation (HP:0004386) | 2.39642580 |
| 59 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.37207878 |
| 60 | Hepatocellular necrosis (HP:0001404) | 2.34475434 |
| 61 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.34371999 |
| 62 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.34176053 |
| 63 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.33210257 |
| 64 | Loss of speech (HP:0002371) | 2.33009904 |
| 65 | 11 pairs of ribs (HP:0000878) | 2.32570214 |
| 66 | Urticaria (HP:0001025) | 2.31798165 |
| 67 | Exertional dyspnea (HP:0002875) | 2.26922223 |
| 68 | Prolonged bleeding time (HP:0003010) | 2.22283774 |
| 69 | Joint stiffness (HP:0001387) | 2.22045327 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.21957143 |
| 71 | Upper motor neuron abnormality (HP:0002127) | 2.21766404 |
| 72 | Abnormal protein glycosylation (HP:0012346) | 2.20888323 |
| 73 | Abnormal glycosylation (HP:0012345) | 2.20888323 |
| 74 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.20888323 |
| 75 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.20888323 |
| 76 | Recurrent abscess formation (HP:0002722) | 2.20793405 |
| 77 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.20744978 |
| 78 | Hypoplasia of the thymus (HP:0000778) | 2.20618725 |
| 79 | Increased muscle lipid content (HP:0009058) | 2.19899695 |
| 80 | Gastrointestinal infarctions (HP:0005244) | 2.19861352 |
| 81 | Cervical subluxation (HP:0003308) | 2.19445082 |
| 82 | Polygenic inheritance (HP:0010982) | 2.18685534 |
| 83 | Nasal polyposis (HP:0100582) | 2.18533547 |
| 84 | Short femoral neck (HP:0100864) | 2.17068996 |
| 85 | Colon cancer (HP:0003003) | 2.16265423 |
| 86 | Episodic fever (HP:0001954) | 2.15563978 |
| 87 | Impaired platelet aggregation (HP:0003540) | 2.15353021 |
| 88 | Abnormal platelet function (HP:0011869) | 2.15353021 |
| 89 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.12897613 |
| 90 | Myositis (HP:0100614) | 2.12676594 |
| 91 | Abnormality of T cells (HP:0002843) | 2.12579296 |
| 92 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.12414873 |
| 93 | Recurrent fungal infections (HP:0002841) | 2.11907931 |
| 94 | Increased intramyocellular lipid droplets (HP:0012240) | 2.10381303 |
| 95 | Abnormality of the nasal mucosa (HP:0000433) | 2.09846458 |
| 96 | Recurrent cutaneous fungal infections (HP:0011370) | 2.09106341 |
| 97 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.09106341 |
| 98 | Increased IgM level (HP:0003496) | 2.08436531 |
| 99 | Recurrent bacterial skin infections (HP:0005406) | 2.07400664 |
| 100 | Thoracic kyphosis (HP:0002942) | 2.06411408 |
| 101 | Pancytopenia (HP:0001876) | 2.02669757 |
| 102 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.01394012 |
| 103 | Lymphoma (HP:0002665) | 2.00566798 |
| 104 | Increased serum ferritin (HP:0003281) | 1.98976695 |
| 105 | Skin rash (HP:0000988) | 1.98401053 |
| 106 | Poikiloderma (HP:0001029) | 1.97500052 |
| 107 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.95744276 |
| 108 | Progressive neurologic deterioration (HP:0002344) | 1.95610656 |
| 109 | Colitis (HP:0002583) | 1.95504401 |
| 110 | Opisthotonus (HP:0002179) | 1.95274334 |
| 111 | Encephalitis (HP:0002383) | 1.93746146 |
| 112 | Lipid accumulation in hepatocytes (HP:0006561) | 1.93652798 |
| 113 | Optic neuritis (HP:0100653) | 1.93000443 |
| 114 | Retrobulbar optic neuritis (HP:0100654) | 1.93000443 |
| 115 | Increased serum lactate (HP:0002151) | 1.92783794 |
| 116 | Spondylolisthesis (HP:0003302) | 1.92214909 |
| 117 | Hypergammaglobulinemia (HP:0010702) | 1.92110930 |
| 118 | Microcytic anemia (HP:0001935) | 1.92092709 |
| 119 | Peritonitis (HP:0002586) | 1.90381023 |
| 120 | Ragged-red muscle fibers (HP:0003200) | 1.89397334 |
| 121 | Poor head control (HP:0002421) | 1.89259403 |
| 122 | Selective tooth agenesis (HP:0001592) | 1.89108426 |
| 123 | Neutropenia (HP:0001875) | 1.89048542 |
| 124 | Epistaxis (HP:0000421) | 1.88283646 |
| 125 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.87809436 |
| 126 | Progressive muscle weakness (HP:0003323) | 1.87788051 |
| 127 | Gingivitis (HP:0000230) | 1.86865965 |
| 128 | Lymphopenia (HP:0001888) | 1.86557090 |
| 129 | Increased hepatocellular lipid droplets (HP:0006565) | 1.84997506 |
| 130 | Mediastinal lymphadenopathy (HP:0100721) | 1.83557238 |
| 131 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.83491743 |
| 132 | Protrusio acetabuli (HP:0003179) | 1.83269494 |
| 133 | Axonal loss (HP:0003447) | 1.81510772 |
| 134 | Vasculitis (HP:0002633) | 1.80065893 |
| 135 | Osteomyelitis (HP:0002754) | 1.79933830 |
| 136 | Hypertriglyceridemia (HP:0002155) | 1.79585729 |
| 137 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.79074571 |
| 138 | Granulocytopenia (HP:0001913) | 1.78616851 |
| 139 | Generalized aminoaciduria (HP:0002909) | 1.78357116 |
| 140 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.76984779 |
| 141 | Fatigue (HP:0012378) | 1.76924147 |
| 142 | Pustule (HP:0200039) | 1.76534233 |
| 143 | Chronic sinusitis (HP:0011109) | 1.75908151 |
| 144 | Mitochondrial inheritance (HP:0001427) | 1.75797689 |
| 145 | Sepsis (HP:0100806) | 1.74543185 |
| 146 | Abnormality of iron homeostasis (HP:0011031) | 1.74065917 |
| 147 | Difficulty running (HP:0009046) | 1.73002083 |
| 148 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.72544236 |
| 149 | Emphysema (HP:0002097) | 1.72376011 |
| 150 | Recurrent lower respiratory tract infections (HP:0002783) | 1.71218905 |
| 151 | Increased CSF lactate (HP:0002490) | 1.71108183 |
| 152 | Eczematoid dermatitis (HP:0000976) | 1.70979192 |
| 153 | Hemorrhage of the eye (HP:0011885) | 1.70502096 |
| 154 | Gastrointestinal stroma tumor (HP:0100723) | 1.67479035 |
| 155 | Absent thumb (HP:0009777) | 1.66922556 |
| 156 | Trismus (HP:0000211) | 1.66857314 |
| 157 | Dicarboxylic aciduria (HP:0003215) | 1.66023363 |
| 158 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.66023363 |
| 159 | Abnormal hemoglobin (HP:0011902) | 1.65930728 |
| 160 | Recurrent skin infections (HP:0001581) | 1.65631052 |
| 161 | Myelodysplasia (HP:0002863) | 1.65027544 |
| 162 | Combined immunodeficiency (HP:0005387) | 1.64979906 |
| 163 | Respiratory difficulties (HP:0002880) | 1.64191760 |
| 164 | Severe combined immunodeficiency (HP:0004430) | 1.64139025 |
| 165 | Skin ulcer (HP:0200042) | 1.63788574 |
| 166 | Abnormality of the anterior horn cell (HP:0006802) | 1.62382337 |
| 167 | Degeneration of anterior horn cells (HP:0002398) | 1.62382337 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 3.60049313 |
| 2 | NME2 | 3.31596172 |
| 3 | ERN1 | 2.87632897 |
| 4 | MAP4K1 | 2.82159641 |
| 5 | EEF2K | 2.81287846 |
| 6 | LIMK1 | 2.42087356 |
| 7 | PKN2 | 2.37792047 |
| 8 | WEE1 | 2.29729671 |
| 9 | BUB1 | 2.25842006 |
| 10 | PIM2 | 2.23189181 |
| 11 | TRIB3 | 2.23162216 |
| 12 | STK16 | 2.17207226 |
| 13 | BCKDK | 2.13250550 |
| 14 | TLK1 | 2.05263128 |
| 15 | IRAK3 | 1.98663528 |
| 16 | SCYL2 | 1.98234124 |
| 17 | EIF2AK3 | 1.92889529 |
| 18 | LRRK2 | 1.90659189 |
| 19 | FLT3 | 1.85084473 |
| 20 | BLK | 1.84112183 |
| 21 | NEK2 | 1.81845697 |
| 22 | ARAF | 1.78535564 |
| 23 | KDR | 1.77677940 |
| 24 | TESK2 | 1.76945973 |
| 25 | DYRK3 | 1.75932180 |
| 26 | BTK | 1.70751169 |
| 27 | RPS6KB2 | 1.69854622 |
| 28 | CDC7 | 1.66080637 |
| 29 | SMG1 | 1.63363701 |
| 30 | VRK1 | 1.61847367 |
| 31 | GRK6 | 1.57873346 |
| 32 | PRPF4B | 1.55327067 |
| 33 | RPS6KA4 | 1.51571288 |
| 34 | TAOK2 | 1.50428524 |
| 35 | ACVR1B | 1.45644311 |
| 36 | MAP3K11 | 1.41623271 |
| 37 | TBK1 | 1.37967719 |
| 38 | RIPK4 | 1.36509840 |
| 39 | VRK2 | 1.33618907 |
| 40 | TGFBR1 | 1.32484786 |
| 41 | MAPKAPK3 | 1.31365889 |
| 42 | KIT | 1.27870069 |
| 43 | EPHB1 | 1.25980684 |
| 44 | BRSK2 | 1.25584870 |
| 45 | MAP2K3 | 1.24887695 |
| 46 | PASK | 1.23156810 |
| 47 | ABL2 | 1.23053593 |
| 48 | TYK2 | 1.21838882 |
| 49 | TAOK1 | 1.21411618 |
| 50 | CDK4 | 1.21348535 |
| 51 | PRKD2 | 1.19789325 |
| 52 | PIM1 | 1.17955375 |
| 53 | EIF2AK1 | 1.17388857 |
| 54 | TEC | 1.17201155 |
| 55 | CSF1R | 1.17086971 |
| 56 | CDK7 | 1.16799748 |
| 57 | ZAP70 | 1.16107631 |
| 58 | TNK2 | 1.15521740 |
| 59 | CSK | 1.13746300 |
| 60 | BRAF | 1.03400298 |
| 61 | SYK | 1.02405057 |
| 62 | ILK | 1.00321961 |
| 63 | MAP3K8 | 0.99394519 |
| 64 | STK4 | 0.98522444 |
| 65 | EPHB2 | 0.97764573 |
| 66 | STK10 | 0.96397862 |
| 67 | TESK1 | 0.94817000 |
| 68 | MAP3K13 | 0.92655375 |
| 69 | AURKB | 0.91292336 |
| 70 | EPHA2 | 0.91038110 |
| 71 | ICK | 0.90508905 |
| 72 | ATR | 0.89544061 |
| 73 | IRAK4 | 0.89542241 |
| 74 | MOS | 0.88465354 |
| 75 | MAP3K14 | 0.87266257 |
| 76 | JAK3 | 0.86227730 |
| 77 | CDC42BPA | 0.86118089 |
| 78 | CDK19 | 0.85558215 |
| 79 | CLK1 | 0.84655643 |
| 80 | PAK4 | 0.82779357 |
| 81 | LMTK2 | 0.81782206 |
| 82 | MARK3 | 0.78281797 |
| 83 | MAP3K1 | 0.76662059 |
| 84 | BRSK1 | 0.74635857 |
| 85 | RPS6KA2 | 0.74115117 |
| 86 | DYRK1B | 0.73865324 |
| 87 | LYN | 0.73663956 |
| 88 | MAPK11 | 0.72749128 |
| 89 | MARK2 | 0.72513191 |
| 90 | PDPK1 | 0.71128909 |
| 91 | IKBKB | 0.68125794 |
| 92 | IKBKE | 0.67680576 |
| 93 | MAPK4 | 0.64572664 |
| 94 | PLK1 | 0.63326752 |
| 95 | SRPK1 | 0.62671639 |
| 96 | AURKA | 0.62318457 |
| 97 | RIPK1 | 0.61422823 |
| 98 | IRAK2 | 0.61264999 |
| 99 | CCNB1 | 0.59931730 |
| 100 | MATK | 0.59631595 |
| 101 | PDK1 | 0.57827854 |
| 102 | TGFBR2 | 0.53518716 |
| 103 | NLK | 0.50945239 |
| 104 | SIK1 | 0.50380650 |
| 105 | MAP2K2 | 0.49328623 |
| 106 | CDK8 | 0.48124663 |
| 107 | FGR | 0.46793230 |
| 108 | TXK | 0.46253251 |
| 109 | LCK | 0.45726089 |
| 110 | GRK7 | 0.45337285 |
| 111 | RPS6KA6 | 0.44605671 |
| 112 | MAP3K3 | 0.43876674 |
| 113 | RPS6KA5 | 0.43658823 |
| 114 | PAK1 | 0.43330524 |
| 115 | CHEK2 | 0.42824551 |
| 116 | ZAK | 0.42561448 |
| 117 | PTK6 | 0.41269496 |
| 118 | DAPK3 | 0.40648877 |
| 119 | SIK2 | 0.39321243 |
| 120 | CSNK2A2 | 0.39208554 |
| 121 | AKT2 | 0.37980181 |
| 122 | MAPKAPK2 | 0.37917801 |
| 123 | RPS6KL1 | 0.37158762 |
| 124 | RPS6KC1 | 0.37158762 |
| 125 | CSNK2A1 | 0.36862982 |
| 126 | TTK | 0.36724854 |
| 127 | HIPK2 | 0.36095568 |
| 128 | MAP3K6 | 0.36011180 |
| 129 | CDK6 | 0.35786227 |
| 130 | PRKCD | 0.34215625 |
| 131 | HCK | 0.34202068 |
| 132 | FES | 0.34119866 |
| 133 | PRKD1 | 0.33850425 |
| 134 | DYRK2 | 0.33206250 |
| 135 | MKNK1 | 0.31557568 |
| 136 | TAOK3 | 0.31520383 |
| 137 | NEK1 | 0.31188670 |
| 138 | FYN | 0.31056735 |
| 139 | RAF1 | 0.30965543 |
| 140 | PIK3CG | 0.30822834 |
| 141 | SIK3 | 0.30764352 |
| 142 | PRKG2 | 0.30724143 |
| 143 | DDR2 | 0.30293508 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.22544490 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.81431218 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.43830411 |
| 4 | Base excision repair_Homo sapiens_hsa03410 | 3.02191035 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 2.46980527 |
| 6 | Homologous recombination_Homo sapiens_hsa03440 | 2.37085365 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.34126382 |
| 8 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.19519622 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.18592597 |
| 10 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.12015524 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.03810055 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.00603879 |
| 13 | Sulfur relay system_Homo sapiens_hsa04122 | 2.00492800 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.00018123 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.96375661 |
| 16 | Asthma_Homo sapiens_hsa05310 | 1.93536572 |
| 17 | Lysosome_Homo sapiens_hsa04142 | 1.79061611 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.74593939 |
| 19 | RNA polymerase_Homo sapiens_hsa03020 | 1.70885728 |
| 20 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.69203718 |
| 21 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.61252573 |
| 22 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.58871624 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.53931788 |
| 24 | Cell cycle_Homo sapiens_hsa04110 | 1.52419347 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.51095592 |
| 26 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.50706293 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.49293148 |
| 28 | Protein export_Homo sapiens_hsa03060 | 1.46046961 |
| 29 | RNA transport_Homo sapiens_hsa03013 | 1.45501940 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.41905001 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.41422259 |
| 32 | Phagosome_Homo sapiens_hsa04145 | 1.33656937 |
| 33 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.32590821 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.28600459 |
| 35 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.27078644 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.26600440 |
| 37 | Salmonella infection_Homo sapiens_hsa05132 | 1.26578133 |
| 38 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.23950849 |
| 39 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.23407840 |
| 40 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.18271110 |
| 41 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.18041499 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.13619112 |
| 43 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.12931113 |
| 44 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.11562190 |
| 45 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.11531004 |
| 46 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.10212181 |
| 47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.07565612 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.03728222 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.02702745 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.99652568 |
| 51 | RNA degradation_Homo sapiens_hsa03018 | 0.97718777 |
| 52 | * Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.97489797 |
| 53 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.94510034 |
| 54 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.94462818 |
| 55 | Purine metabolism_Homo sapiens_hsa00230 | 0.92010640 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.90977836 |
| 57 | Parkinsons disease_Homo sapiens_hsa05012 | 0.90763976 |
| 58 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.90454843 |
| 59 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.89858573 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.85993482 |
| 61 | Legionellosis_Homo sapiens_hsa05134 | 0.85462795 |
| 62 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.84605169 |
| 63 | Leishmaniasis_Homo sapiens_hsa05140 | 0.83757181 |
| 64 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.82871237 |
| 65 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.81610520 |
| 66 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.81120988 |
| 67 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.80538189 |
| 68 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.80306707 |
| 69 | Apoptosis_Homo sapiens_hsa04210 | 0.79859553 |
| 70 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78943062 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.78525312 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.76759967 |
| 73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.75784767 |
| 74 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.74637659 |
| 75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74526274 |
| 76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73598805 |
| 77 | Measles_Homo sapiens_hsa05162 | 0.73391281 |
| 78 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73294313 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.73109433 |
| 80 | * Carbon metabolism_Homo sapiens_hsa01200 | 0.72662864 |
| 81 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72540296 |
| 82 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.71096744 |
| 83 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.70602275 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70182521 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69996520 |
| 86 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69272261 |
| 87 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.68163079 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.67752983 |
| 89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67092164 |
| 90 | Shigellosis_Homo sapiens_hsa05131 | 0.66884494 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66669532 |
| 92 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.66548059 |
| 93 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.66272908 |
| 94 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.65825515 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64403871 |
| 96 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.63040079 |
| 97 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62881765 |
| 98 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.62224248 |
| 99 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61484429 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60522393 |
| 101 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.60479394 |
| 102 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.60271142 |
| 103 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.57920234 |
| 104 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.56911623 |
| 105 | Huntingtons disease_Homo sapiens_hsa05016 | 0.56389001 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56364684 |
| 107 | Hepatitis B_Homo sapiens_hsa05161 | 0.55127300 |
| 108 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.55067224 |
| 109 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.54595632 |
| 110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52928232 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52050254 |
| 112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51781676 |
| 113 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51756455 |
| 114 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.51532867 |
| 115 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.51254756 |
| 116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50986990 |
| 117 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49588286 |
| 118 | Alcoholism_Homo sapiens_hsa05034 | 0.49141892 |
| 119 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.47490164 |
| 120 | Bladder cancer_Homo sapiens_hsa05219 | 0.47469112 |
| 121 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45596629 |
| 122 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45396377 |
| 123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44473190 |
| 124 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44469790 |
| 125 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.44342690 |
| 126 | Influenza A_Homo sapiens_hsa05164 | 0.44162962 |
| 127 | Basal transcription factors_Homo sapiens_hsa03022 | 0.43378127 |
| 128 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.42707168 |
| 129 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40901524 |
| 130 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.39081363 |
| 131 | Peroxisome_Homo sapiens_hsa04146 | 0.38664903 |
| 132 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38523945 |
| 133 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.37050304 |
| 134 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.36975750 |
| 135 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.36935043 |
| 136 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.36931333 |
| 137 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.36335296 |
| 138 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.34286341 |
| 139 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33135720 |
| 140 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33028364 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31976538 |
| 142 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.31738666 |
| 143 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.31719323 |
| 144 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.30460126 |
| 145 | Pertussis_Homo sapiens_hsa05133 | 0.29000184 |
| 146 | Alzheimers disease_Homo sapiens_hsa05010 | 0.28855444 |
| 147 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.25045790 |

